neostigmine has been researched along with Chicken Pox in 1 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Excerpt | Relevance | Reference |
---|---|---|
"Myasthenia gravis is an autoimmune disease of neuromuscular junctions." | 1.34 | Post-varicella myasthenia gravis. ( Batra, P; Chaturvedi, P; Saha, A; Vilhekar, KY, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Saha, A | 1 |
Batra, P | 1 |
Vilhekar, KY | 1 |
Chaturvedi, P | 1 |
1 other study available for neostigmine and Chicken Pox
Article | Year |
---|---|
Post-varicella myasthenia gravis.
Topics: Chickenpox; Child, Preschool; Cholinesterase Inhibitors; Humans; Male; Myasthenia Gravis; Neostigmin | 2007 |